The biofilm eradication activity of acetic acid in the management of periprosthetic joint infection
- PMID: 30258571
- PMCID: PMC6138806
- DOI: 10.1302/2046-3758.78.BJR-2018-0045.R1
The biofilm eradication activity of acetic acid in the management of periprosthetic joint infection
Abstract
Objectives: Periprosthetic joint infection following joint arthroplasty surgery is one of the most feared complications. The key to successful revision surgery for periprosthetic joint infections, regardless of treatment strategy, is a thorough deep debridement. In an attempt to limit antimicrobial and disinfectant use, there has been increasing interest in the use of acetic acid as an adjunct to debridement in the management of periprosthetic joint infections. However, its effectiveness in the eradication of established biofilms following clinically relevant treatment times has not been established. Using an in vitro biofilm model, this study aimed to establish the minimum biofilm eradication concentration (MBEC) of acetic acid following a clinically relevant treatment time.
Materials and methods: Using a methicillin-sensitive Staphylococcus aureus (MSSA) reference strain and the dissolvable bead assay, biofilms were challenged by 0% to 20% acetic acid (pH 4.7) for ten minutes, 20 minutes, 180 minutes, and 24 hours.
Results: The MBEC of acetic acid was found to be: 15%, 11%, 3.2%, and 0.8% following a ten-minute, 20-minute, 180-minute, and 24-hour treatment, respectively.
Conclusion: This study found that the MBEC of acetic acid following a 10- or 20-minute treatment time exceeded its safety threshold, making these concentrations unsuitable as a topical debridement adjunct. However, a clinically acceptable concentration (5%) was still found to eliminate 96.1% of biofilm-associated MSSA following a 20-minute treatment time.Cite this article: S. T. J. Tsang, P. J. Gwynne, M. P. Gallagher, A. H. R. W. Simpson. The biofilm eradication activity of acetic acid in the management of periprosthetic joint infection. Bone Joint Res 2018;7:517-523. DOI: 10.1302/2046-3758.78.BJR-2018-0045.R1.
Keywords: Acetic acid; Infection; Revision surgery.
Conflict of interest statement
Conflict of interest: The authors declare that there are no conflicts of interest.
Figures




Similar articles
-
Underestimation of Staphylococcus aureus (MRSA and MSSA) carriage associated with standard culturing techniques: One third of carriers missed.Bone Joint Res. 2018 Jan;7(1):79-84. doi: 10.1302/2046-3758.71.BJR-2017-0175.R1. Bone Joint Res. 2018. PMID: 29330346 Free PMC article.
-
Biofilm properties in relation to treatment outcome in patients with first-time periprosthetic hip or knee joint infection.J Orthop Translat. 2021 Aug 19;30:31-40. doi: 10.1016/j.jot.2021.05.008. eCollection 2021 Sep. J Orthop Translat. 2021. PMID: 34485075 Free PMC article.
-
Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms.J Antimicrob Chemother. 2018 Jul 1;73(7):1830-1840. doi: 10.1093/jac/dky087. J Antimicrob Chemother. 2018. PMID: 29554250
-
Current therapeutic interventions combating biofilm-related infections in orthopaedics : a systematic review of in vivo animal studies.Bone Joint Res. 2022 Oct;11(10):700-714. doi: 10.1302/2046-3758.1110.BJR-2021-0495.R3. Bone Joint Res. 2022. PMID: 36214177 Free PMC article.
-
Periprosthetic joint infection: current concepts and outlook.EFORT Open Rev. 2019 Jul 29;4(7):482-494. doi: 10.1302/2058-5241.4.180092. eCollection 2019 Jul. EFORT Open Rev. 2019. PMID: 31423332 Free PMC article. Review.
Cited by
-
Debridement for prosthetic joint infections: future therapies.Bone Joint Res. 2020 Jun 30;9(6):311-313. doi: 10.1302/2046-3758.96.BJR-2020-0238. eCollection 2020 Jun. Bone Joint Res. 2020. PMID: 32637074 Free PMC article. No abstract available.
-
Pursuit of the ideal antiseptic irrigation solution in the management of periprosthetic joint infections.J Bone Jt Infect. 2021 May 26;6(6):189-198. doi: 10.5194/jbji-6-189-2021. eCollection 2021. J Bone Jt Infect. 2021. PMID: 34109103 Free PMC article. Review.
-
Does a Specific Sequential Combination of Antiseptic Solutions for Chemical Debridement in Periprosthetic Joint Infection Improve Outcomes vs. Solution Alone? An In Vivo Study.Antibiotics (Basel). 2024 Dec 17;13(12):1225. doi: 10.3390/antibiotics13121225. Antibiotics (Basel). 2024. PMID: 39766614 Free PMC article.
-
Irrigation Solutions in Total Joint Arthroplasty.Spartan Med Res J. 2022 Sep 6;7(2):37502. doi: 10.51894/001c.37502. eCollection 2022. Spartan Med Res J. 2022. PMID: 36128028 Free PMC article.
-
Implant materials and prosthetic joint infection: the battle with the biofilm.EFORT Open Rev. 2019 Nov 5;4(11):633-639. doi: 10.1302/2058-5241.4.180095. eCollection 2019 Nov. EFORT Open Rev. 2019. PMID: 31754470 Free PMC article. Review.
References
-
- Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004;351:1645-1654. - PubMed
-
- Vanhegan IS, Malik AK, Jayakumar P, Ul Islam S, Haddad FS. A financial analysis of revision hip arthroplasty: the economic burden in relation to the national tariff. J Bone Joint Surg [Br] 2012;94-B:619-623. - PubMed
-
- British Orthopaedic Association. Getting It Right First Time. 2015. https://www.boa.ac.uk/pro-practice/getting-it-right-first-time/ (date last accessed 28 June 2017).
-
- Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002;23:183-189. - PubMed
-
- Huotari K, Lyytikäinen O, Ollgren J, et al. Disease burden of prosthetic joint infections after hip and knee joint replacement in Finland during 1999-2004: capture-recapture estimation. J Hosp Infect 2010;75:205-208. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources